Latest Us Market News

Xero Limited reveals new AI product demonstrations and updates on Melio’s integration, reaffirming ambitious US growth and FY28 revenue targets.

Credit Corp Group posted a steady first half with 4% revenue growth and flat net profit, setting the stage for a robust second half driven by increased lending and debt buying investments.

Peak Processing Limited has raised $2.72 million through a discounted share placement to fund growth and operational improvements in its Canadian and US markets. Key directors are backing the raise, signalling confidence in the company’s strategy.

Orthocell Ltd reports steady progress in commercialising its nerve repair product Remplir in the US, with sales growth, expanded distributor networks, and manufacturing upgrades underpinning its path to profitability.

Adheris Health has expanded its operating cost reduction program, aiming for more than 30% savings by FY27, while refocusing on high-growth pharmaceutical categories and enhancing its AI-powered patient engagement platform.

New Frontier Minerals has completed the Stage 1 earn-in to secure an 85% interest in a pivotal tenement at its Harts Range Heavy Rare Earths Project, positioning the company strongly ahead of imminent assay results.

Resolution Minerals has announced a significant gold discovery at its Golden Gate North Prospect, marking a pivotal shift from exploration to development. The company also advances its critical minerals strategy with key acquisitions and a $25 million capital raise.

American West Metals has reported a substantial expansion of its Storm Copper Project resources in Canada alongside promising critical metals discoveries at its West Desert Project in Utah, underpinning its strategic growth and US market engagement.

Thrive Tribe Technologies reported a $186,000 net operating cash outflow in Q2 FY26, offset by a $300,000 equity raise to fund growth initiatives and operational expansion.

Hydrix Limited reported $2.3 million in revenue for Q2 FY26 and secured a $2.5 million initial contract with SynCardia Systems to develop a fully implantable artificial heart, setting a positive tone for 2026.

GCM Corporation’s latest quarterly report confirms its VHD thermal management technology outperforms copper and aluminium, while commercial and US listing plans gain momentum.

4DMedical Limited has responded to ASX queries over its announcements of commercial agreements with leading US academic medical centres, clarifying its disclosure approach and denying ramping allegations ahead of a $150 million capital raise.